| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President/CEO | Jan 30, 2026 | Buy | $0.89 | 28,100 | 25,009 | 373,720 | Feb 02, 2026, 04:08 PM | |
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President/CEO | Apr 03, 2025 | Buy | $1.84 | 5,500 | 10,110 | 345,620 | Apr 04, 2025, 07:30 AM | |
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President/CEO | Oct 23, 2024 | Buy | $3.91 | 500 | 1,957 | 333,395 | Oct 24, 2024, 08:30 AM | |
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President/CEO | Oct 15, 2024 | Buy | $2.90 | 250 | 725 | 332,895 | Oct 16, 2024, 08:31 AM | |
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President/CEO | Oct 10, 2024 | Buy | $2.54 | 150 | 381 | 331,645 | Oct 15, 2024, 08:31 AM | |
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President/CEO | Oct 14, 2024 | Buy | $2.59 | 1,000 | 2,590 | 332,645 | Oct 15, 2024, 08:31 AM | |
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President, CEO | Mar 13, 2024 | Buy | $7.29 | 2,000 | 14,580 | 324,770 | Mar 14, 2024, 08:51 PM | |
| APRE | Aprea Therapeutics, Inc. | Oren Gilad | President, CEO | Aug 23, 2022 | Conversion | - | 6,045,100 | - | 6,375,414 | Mar 13, 2023, 06:30 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More